Jovelle L. Fernandez

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Lifestyle restrictions are associated with impaired quality of life but not reduction in relapse in ulcerative colitis.

Lifestyle restrictions are associated with impaired quality of life but not reduction in relapse in ulcerative colitis.

Journal: Intestinal research

Published: November 29, 2024

Real-World Effectiveness and Safety of Vedolizumab in Patients ≥ 70 Versus < 70 Years With Ulcerative Colitis: Multicenter Retrospective Study.

Real-World Effectiveness and Safety of Vedolizumab in Patients ≥ 70 Versus < 70 Years With Ulcerative Colitis: Multicenter Retrospective Study.

Journal: Journal of gastroenterology and hepatology

Published: September 19, 2024

The duration of prior anti-tumor necrosis factor agents is associated with the effectiveness of vedolizumab in patients with ulcerative colitis: a real-world multicenter retrospective study.

The duration of prior anti-tumor necrosis factor agents is associated with the effectiveness of vedolizumab in patients with ulcerative colitis: a real-world multicenter retrospective study.

Journal: Intestinal research

Published: August 09, 2024

Correction: Association of ulcerative colitis symptom severity and proctocolectomy with multidimensional patient-reported outcomes: a cross-sectional study.

Correction: Association of ulcerative colitis symptom severity and proctocolectomy with multidimensional patient-reported outcomes: a cross-sectional study.

Journal: Journal of gastroenterology

Published: May 30, 2024

Factors affecting 1-year persistence with vedolizumab for ulcerative colitis: a multicenter, retrospective real-world study.

Factors affecting 1-year persistence with vedolizumab for ulcerative colitis: a multicenter, retrospective real-world study.

Journal: Intestinal research

Published: May 01, 2024

Week 2 remission with vedolizumab as a predictor of long-term remission in patients with ulcerative colitis: a multicenter, retrospective, observational study.

Week 2 remission with vedolizumab as a predictor of long-term remission in patients with ulcerative colitis: a multicenter, retrospective, observational study.

Journal: Intestinal research

Published: April 09, 2024

Safety and effectiveness of rasagiline in patients with Parkinson's disease in Japan: a post-marketing surveillance study.

Safety and effectiveness of rasagiline in patients with Parkinson's disease in Japan: a post-marketing surveillance study.

Journal: Expert opinion on drug safety

Published: December 21, 2023

Development and validation of a 13-item short version of the inflammatory bowel disease self-efficacy scale.

Development and validation of a 13-item short version of the inflammatory bowel disease self-efficacy scale.

Journal: BMC gastroenterology

Published: November 13, 2023

A web-based survey on self-management for patients with inflammatory bowel disease in Japan.

A web-based survey on self-management for patients with inflammatory bowel disease in Japan.

Journal: PloS one

Published: March 17, 2023

Survey on the Impact of the COVID-19 Pandemic on Patients with Parkinson's Disease and Their Caregivers in Japan.

Survey on the Impact of the COVID-19 Pandemic on Patients with Parkinson's Disease and Their Caregivers in Japan.

Journal: Patient preference and adherence

Published: December 21, 2022

Association of ulcerative colitis symptom severity and proctocolectomy with multidimensional patient-reported outcomes: a cross-sectional study.

Association of ulcerative colitis symptom severity and proctocolectomy with multidimensional patient-reported outcomes: a cross-sectional study.

Journal: Journal of gastroenterology

Published: December 20, 2022

Correction to: A Computational Platform Integrating a Mechanistic Model of Crohn's Disease for Predicting Temporal Progression of Mucosal Damage and Healing.

Correction to: A Computational Platform Integrating a Mechanistic Model of Crohn's Disease for Predicting Temporal Progression of Mucosal Damage and Healing.

Journal: Advances in therapy

Published: December 13, 2022

Showing 1-12 of 45

Last Updated: 09/26/2026